Echocardiography evaluation of bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective observational cohort study
- PMID: 33633939
- PMCID: PMC7882291
- DOI: 10.21037/tp-20-192
Echocardiography evaluation of bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective observational cohort study
Abstract
Background: Echocardiography has poor accuracy in grading the severity of pulmonary hypertension (PH) compared to cardiac catheterization. However, the relationship between degree of PH and prognostic outcomes remains uncertain. Our primary objective was to determine whether echocardiogram-assessed PH severity is associated with mortality and hospital readmission in the first year of life.
Methods: A retrospective cohort study of infants born less than 32 weeks of gestational age with bronchopulmonary dysplasia (BPD) underwent echocardiography was performed. Echocardiograms were performed at 36-38 weeks postmenstrual age. Data during hospitalization and post-discharge collected at 1-year age were analyzed with cox regression models and logistic regression models to identify the association of PH severity with mortality and readmission. Area under curve (AUC) was calculated to examine the accuracy of these models to reflect the likelihood of outcomes.
Results: Fifty-six of 237 (23.6%) infants were diagnosed as PH. Moderate and severe PH was significantly associated with mortality during the first one year of life (moderate PH vs. none HR =26.58, 95% CI: 4.40-160.78, P<0.001; severe PH vs. none HR =36.49, 95% CI: 5.65-235.84, P<0.001). Male, preeclampsia and inhaled nitric oxide were also associated with mortality. Mild PH was significantly associated with readmission (OR =2.42, 95% CI: 1.12-5.26, P=0.025), but not associated with mortality (HR =2.09, 95% CI: 0.43-10.18, P=0.36). The PH severity model based on echocardiography accurately informed mortality (AUC 0.79).
Conclusions: Echocardiogram-assessed PH severity is associated with prognostic outcomes, including mortality and readmission in very preterm infants with BPD. The severity of PH based on echocardiography is a potential predictor of mortality in the first year of life.
Keywords: Bronchopulmonary dysplasia (BPD); echocardiography; prognosis; pulmonary hypertension (PH).
2021 Translational Pediatrics. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tp-20-192). The authors have no conflicts of interest to declare.
Figures




Similar articles
-
Correlating Severity of Pulmonary Hypertension by Echocardiogram with Mortality in Premature Infants with Bronchopulmonary Dysplasia.Am J Perinatol. 2024 Dec;41(16):2206-2213. doi: 10.1055/s-0044-1786544. Epub 2024 May 2. Am J Perinatol. 2024. PMID: 38698596
-
[Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants].Zhonghua Er Ke Za Zhi. 2020 Sep 2;58(9):747-752. doi: 10.3760/cma.j.cn112140-20200327-00310. Zhonghua Er Ke Za Zhi. 2020. PMID: 32872715 Chinese.
-
Pulmonary hypertension in a neonatologist-performed echocardiographic follow-up of bronchopulmonary dysplasia.Eur J Pediatr. 2021 Jun;180(6):1711-1720. doi: 10.1007/s00431-021-03954-y. Epub 2021 Jan 21. Eur J Pediatr. 2021. PMID: 33474582
-
Pulmonary hypertension in bronchopulmonary dysplasia.Semin Perinatol. 2013 Apr;37(2):124-31. doi: 10.1053/j.semperi.2013.01.009. Semin Perinatol. 2013. PMID: 23582967 Free PMC article. Review.
-
Pulmonary hypertension in bronchopulmonary dysplasia.Pediatr Res. 2021 Feb;89(3):446-455. doi: 10.1038/s41390-020-0993-4. Epub 2020 Jun 10. Pediatr Res. 2021. PMID: 32521539 Free PMC article. Review.
Cited by
-
Inhaled Nitric Oxide for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Systematic Review and Narrative Synthesis.Neonatology. 2025;122(4):467-476. doi: 10.1159/000545034. Epub 2025 Mar 3. Neonatology. 2025. PMID: 40031892 Free PMC article.
-
Long-term impact of late pulmonary hypertension requiring medication in extremely preterm infants with severe bronchopulmonary dysplasia.Sci Rep. 2024 Apr 15;14(1):8705. doi: 10.1038/s41598-024-58977-w. Sci Rep. 2024. PMID: 38622180 Free PMC article.
-
Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia.J Perinatol. 2024 Feb;44(2):280-287. doi: 10.1038/s41372-023-01809-y. Epub 2023 Oct 31. J Perinatol. 2024. PMID: 37907796 Free PMC article. Clinical Trial.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources